Skip to main content
Canna~Fangled Abstracts

Antiviral effect of cannabidiol on K18-hACE2 transgenic mice infected with SARS-CoV-2

By September 11, 2024September 16th, 2024No Comments

. 2024 Sep;28(17):e70030.

doi: 10.1111/jcmm.70030.

Hivda Ulbegi Polat 1, Hicret Asli Yalcin 1, Deniz Köm 1, Özge Aksoy 1 2, Irem Abaci 1 3, Arzu Tas Ekiz 1, Müge Serhatli 1, Selma Onarici 1
Affiliations 

Abstract

The aim of this study was to determine the antiviral activity of cannabidiol (CBD) against SARS-CoV-2 infection. CBD is the second most studied cannabinoid obtained from Cannabis plants. We investigated the potential use of CBD, which has so far proven to have a positive effect on different diseases, in the SARS-CoV-2 infection. To test this, in vivo studies were carried out using K18-hACE2 transgenic mice. To reveal the potential therapeutic effect of the CBD at the histopathological and molecular level challenge experiments were performed. The study was designed with two groups (n = 10) and in the treatment group animals were infected with SARS-CoV-2 virus strain B.1.1.7 alpha before the administration of CBD. While the disease progressed and resulted in death in the control group that was infected by the virus alone, it was observed that the infection slowed down and the survival rate increased in the mice treated with CBD along with the virus. In this study, K18-hACE2 transgenic mice infected with the wild SARS-CoV-2 virus were used to investigate and prove the antiviral activity of CBD.

Keywords: CBD; COVID‐19; SARS‐CoV‐2; antiviral; cannabinoid; cannabis; mice.

PubMed Disclaimer

References

REFERENCES

    1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus‐infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061‐1069. doi:10.1001/jama.2020.1585
    1. Winkler ES, Bailey AL, Kafai NM, et al. SARS‐CoV‐2 infection of human ACE2‐transgenic mice causes severe lung inflammation and impaired function. Nat Immunol. 2020;21(11):1327‐1335. doi:10.1038/s41590-020-0778-2
    1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727‐733. doi:10.1056/nejmoa2001017
    1. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘cytokine storm’ in COVID‐19. J Infect. 2020;80(6):607‐613. doi:10.1016/j.jinf.2020.03.037
    1. Akindele AJ, Sowemimo A, Agunbiade FO, et al. Bioprospecting for anti‐COVID‐19 interventions from African medicinal plants: a review. Nat Prod Commun. 2022;17(5):1934578X221096968. doi:10.1177/1934578X221096968

MeSH terms

Substances

Leave a Reply